Validation of the gerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan

United European Gastroenterology Journal

Volumn 1, Issue 3, 2013, Pages 175-183

  Suzuki, Hidekazu ^a   Matsuzaki, Juntaro ^a   Okada, Sawako ^a   Hirata, Kenro ^a   Fukuhara, Seiichiro ^a   Hibi, Toshifumi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cutoff; GERD; GerdQ; Questionnaire; Unmet medical need

Indexed keywords

ADULT; ARTICLE; ESOPHAGITIS; FEMALE; GASTROESOPHAGEAL REFLUX; GERDQ QUESTIONNAIRE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

EID: 85006198870     PISSN: 20506406     EISSN: 20506414     Source Type: Journal    
DOI: 10.1177/2050640613485238     Document Type: Article

References (21)

1. Fujiwara Y and Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol 2009; 44: 518–534.
2. Kahrilas PJ, Shaheen NJ, Vaezi MF, et al. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology 2008; 135: 1383–1391.
3. Jones R, Junghard O, Dent J, et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther 2009; 30: 1030–1038.
4. Jonasson C, Wernersson B, Hoff DA, et al. Validation of the GerdQ questionnaire for the diagnosis of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2013.
5. Jonasson C, Moum B, Bang C, et al. Randomised clinical trial: a comparison between a GerdQ-based algorithm and an endoscopy-based approach for the diagnosis and initial treatment of GERD. Aliment Pharmacol Ther 2012; 35: 1290–1300.
6. Wong BC and Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol 2006; 4: 398–407.
7. Kinoshita Y, Kawanami C, Kishi K, et al. Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese. Gut 1997; 41: 452–458.
8. Kinoshita Y, Adachi K, Hongo M, et al. Systematic review of the epidemiology of gastroesophageal reflux disease in Japan. J Gastroenterol 2011; 46: 1092–1103.
9. Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998; 33: 1023–1029.
10. Mishima I, Adachi K, Arima N, et al. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol 2005; 40: 1005–1009.
11. Iwasaki E, Suzuki H, Sugino Y, et al. Decreased levels of adiponectin in obese patients with gastroesophageal reflux evaluated by videoesophagography: possible relationship between gastroesophageal reflux and metabolic syndrome. J Gastroenterol Hepatol 2008; 23(Suppl 2): S216–S221.
12. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900–1920.
13. Alberti KG, Zimmet P and Shaw J. The metabolic syndrome _ a new worldwide definition. Lancet 2005; 366: 1059–1062.
14. Jung HK. Epidemiology of gastroesophageal reflux disease in Asia: a systematic review. J Neurogastroenterol Motil 2011; 17: 14–27.
15. Lee YC, Yen AM, Tai JJ, et al. The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease. Gut 2009; 58: 174–181.
16. Netinatsunton N, Attasaranya S, Ovartlarnporn B, et al. The value of Carlsson-dent questionnaire in diagnosis of gastroesophageal reflux disease in area with lowprevalence of gastroesophageal reflux disease. J Neurogastroenterol Motil 2011; 17: 164–168.
17. Matsuzaki J, Suzuki H, Iwasaki E, et al. Serum lipid levels are positively associated with non-erosive reflux disease, but not with functional heartburn. Neurogastroenterol Motil 2010; 22: 965–970, e251.
18. Zerbib F, Belhocine K, Simon M, et al. Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease. Gut 2012; 61: 501–506.
19. Savarino E, Marabotto E, Zentilin P, et al. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Dig Liver Dis 2011; 43: 542–547.
20. Slaughter JC, Goutte M, Rymer JA, et al. Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2011; 9: 868–874.
21. Savarino E, Tutuian R, Zentilin P, et al. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease:study using combined impedance-pH off therapy. Am J Gastroenterol 2010; 105: 1053–1061.